1 year agoFrom Malaria to COVID-19: Sixty Degrees Pharma CEO Geoff Dow's Perspective on Infectious Disease SolutionsRedChip
1 year agoGraphene and Beyond: Exploring Graphex's Role in the EV and Renewable Energy MarketsRedChip
11 months agoRevolutionizing Medicine: A Conversation with BullFrog AI's CEO on AI-Driven Drug DevelopmentRedChip
11 months agoIn the Spotlight: BioVie's (NASDAQ: BIVI) Quest to Tackle Alzheimer's, Parkinson's, and MoreRedChip
1 year agoAridis Pharma Founder & CEO Discusses Upcoming Milestones for its Late-Stage PipelineRedChip
1 year agoReviva: Developing Next-Generation Therapies for Diseases with Significant Unmet NeedsRedChip
9 months agoBioVie(NASDAQ:BIVI): Advancing Transformative Therapies for Neurodegeneration and Liver DiseaseRedChip